Speaker Presentations - Day Two

From Evidence to Policy to Practice

Tuesday, April 4, 2006

Health Technology Strategy 1.0 Update

• Dr. Jill Sanders, President & CEO, CADTH

Bridging the Gap: A proposal for collaboration in the management of health technologies in Canada

• Dr. E.W. Hunt, Chair, Board of Directors, CADTH

COMPUS and CDR Update

• Barb Shea, Vice-President, Common Drug Review (CDR) and Canadian Optimal Medication Prescribing and Utilization Service (COMPUS), CADTH

Drug /Device Combinations: The Convergence of Pharmaceutical and Biomaterial Science

• David Ames, Director, Health Economics and Emerging Technologies, Johnson & Johnson Medical Products

Long-Term Cost-Effectiveness Analysis (CEA) of a Nurse-Led Multifaceted Intervention Aimed at Improving Diabetes Management: Results from a Computerized Simulation Model

• Dr. Daria O'Reilly, PATH, McMaster University

Testing for Positive Breast Cancer: A Cost-Effectiveness Analysis

• Dr. Nandini Dendukuri, Research Scientist, Technology Assessment Unit, McGill University

The Cost Effectiveness of Sirolimus Eluting Stents - Evaluating the Evaluations

• Dr. Nandini Dendukuri, Research Scientist, Technology Assessment Unit, McGill University

Operationalizing Best Practice with Consideration of Research and Determinants of Health

• Diana Lawlor, QEII Health Sciences Centre
• Barbara Currie, Diabetes Case Management Coordinator, QEII Health Sciences Centre

The Canadian Academic Detailing Collaboration: Putting evidence into practice

• Dr. Michael Allen, Director Special Projects, Dalhousie CME

Developing Background Information for Evidence-Based Best Practices for the Prescribing and Use of Proton Pump Inhibitors in Canada

• Sumeet Singh, Research Officer, COMPUS, CADTH

The Cochrane Library: What’s really in it for HTA decision makers?

• Miranda Cumpston, Education Coordinator,Canadian Cochrane Network and Centre (convenor)
• Emma Irvin, Information Systems Institute for Work & Health Manager
• Jessie McGowan, Senior Information Scientist Cochrane Effective Practice and Organisation of Care Group

Increasing Capacity for Use of HTA in Health Authorities: The Ambassador Program

• Paul Taenzer, Calgary Health Authority (convenor)
• Christa Harstall, Associate Director, HTA Unit, Alberta Heritage Foundation for Medical Research
• Dr. Don Juzwishin, Director, HTA Alberta Heritage Foundation for Medical Research

Moving the Health Agenda From Evidence to Policy

• Dr. Penny Ballem, Deputy Minister, British Columbia Ministry of Health

Ethical Issues in Technology Assessment

• Nuala Kenny, Professor, Department of Bioethics, Dalhousie University

NBIC/Enhancement-Medicine, Emerging technologies (Nano, Bio, Info, Cogno) and the Concept of Health: A New Challenge for HTA, Health Research, and Health Policy

• Gregor Wolbring, Researcher, University of Calgary